IM Cannabis Corp. (IMCC)
IMCC Stock Price Chart
Explore IM Cannabis Corp. interactive price chart. Choose custom timeframes to analyze IMCC price movements and trends.
IMCC Company Profile
Discover essential business fundamentals and corporate details for IM Cannabis Corp. (IMCC) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
20 May 2020
Employees
95.00
Website
https://www.imcannabis.comCEO
Oren Shuster
Description
IM Cannabis Corp. specializes in the cultivation, production, and provision of medicinal cannabis goods throughout international markets such as Israel, Germany, and Canada. The company offers a range of cannabis products, including flowers and specifically formulated cannabis extracts, marketed under its IMC brand. Furthermore, it supplies dried flower, pre-rolled products, and compressed hashish via its WAGNERS and Highland Grow labels. IM Cannabis Corp. serves a broad customer base, addressing the needs of both medical patients and adult recreational consumers. Its corporate headquarters are located in Tel Aviv-Yafo, Israel.
IMCC Financial Timeline
Browse a chronological timeline of IM Cannabis Corp. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 17 Aug 2026
Earnings released on 13 May 2026
EPS came in at -$0.28 , while revenue for the quarter reached $4.54m .
Earnings released on 30 Mar 2026
EPS came in at -$0.86 falling short of the estimated $0.09 by -1.10k%, while revenue for the quarter reached $8.19m , missing expectations by -47.70%.
Earnings released on 13 Nov 2025
EPS came in at -$0.54 falling short of the estimated -$0.02 by -2.23k%, while revenue for the quarter reached $9.93m , missing expectations by -30.40%.
Earnings released on 12 Aug 2025
EPS came in at -$0.07 surpassing the estimated -$0.14 by +48.79%, while revenue for the quarter reached $9.32m , missing expectations by -27.63%.
Earnings released on 15 May 2025
EPS came in at $0.06 surpassing the estimated -$0.25 by +123.56%, while revenue for the quarter reached $8.78m , missing expectations by -23.56%.
Earnings released on 31 Mar 2025
EPS came in at -$0.23 surpassing the estimated -$0.39 by +41.03%, while revenue for the quarter reached $9.27m , missing expectations by -8.15%.
Earnings released on 14 Nov 2024
EPS came in at -$0.30 surpassing the estimated -$0.70 by +57.14%, while revenue for the quarter reached $10.23m , missing expectations by -29.37%.
Earnings released on 14 Aug 2024
EPS came in at -$0.17 surpassing the estimated -$0.84 by +79.76%, while revenue for the quarter reached $10.79m , beating expectations by +12.73%.
Stock split effective on 12 Jul 2024
Shares were split 1 : 6 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 8 May 2024
EPS came in at -$0.96 matching the estimated -$0.96, while revenue for the quarter reached $8.88m , missing expectations by -16.20%.
Earnings released on 28 Mar 2024
EPS came in at -$1.08 falling short of the estimated -$0.96 by -12.50%, while revenue for the quarter reached $8.05m , missing expectations by -33.23%.
Earnings released on 13 Nov 2023
EPS came in at -$0.72 surpassing the estimated -$0.96 by +25.00%, while revenue for the quarter reached $9.13m , missing expectations by -12.61%.
Earnings released on 14 Aug 2023
EPS came in at -$1.14 falling short of the estimated -$0.78 by -46.15%, while revenue for the quarter reached $9.97m , missing expectations by -25.82%.
Earnings released on 15 May 2023
EPS came in at $0.12 surpassing the estimated -$1.20 by +110.00%, while revenue for the quarter reached $9.74m , missing expectations by -29.46%.
Earnings released on 29 Mar 2023
EPS came in at -$1.32 falling short of the estimated -$0.28 by -371.43%, while revenue for the quarter reached $10.78m , missing expectations by -3.25%.
Stock split effective on 17 Nov 2022
Shares were split 1 : 10 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 14 Nov 2022
EPS came in at -$3.00 surpassing the estimated -$3.60 by +16.67%, while revenue for the quarter reached $10.35m , missing expectations by -43.76%.
Earnings released on 15 Aug 2022
EPS came in at -$14.40 falling short of the estimated -$1.80 by -700.00%, while revenue for the quarter reached $18.49m , missing expectations by -10.12%.
Earnings released on 12 May 2022
EPS came in at -$7.80 falling short of the estimated -$1.20 by -550.00%, while revenue for the quarter reached $10.40m , missing expectations by -47.86%.
Earnings released on 31 Mar 2022
EPS came in at -$9.00 falling short of the estimated -$1.80 by -400.00%, while revenue for the quarter reached $15.71m , beating expectations by +8.12%.
Earnings released on 24 Nov 2021
EPS came in at -$8.40 falling short of the estimated -$0.60 by -1.30k%, while revenue for the quarter reached $6.34m , missing expectations by -95.92%.
Earnings released on 16 Aug 2021
EPS came in at -$2.30 falling short of the estimated -$0.20 by -1.05k%, while revenue for the quarter reached $8.96m .
IMCC Stock Performance
Access detailed IMCC performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
